Cardinal Health, Inc. (CAH) Enterprise Value (EV): $57.76B
The enterprise value (EV) for Cardinal Health, Inc. (CAH) is $57.76B as of Wednesday, June 17, 2026.
CAH Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$57.76B
CAH Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cardinal Health, Inc. (CAH) | $53.10B | $57.76B |
| Becton, Dickinson and Company (BDX)vs › | $52.59B | $60.50B |
| Cencora, Inc. (COR)vs › | $54.76B | $66.93B |
| IDEXX Laboratories, Inc. (IDXX)vs › | $45.20B | $55.08B |
| Humana Inc. (HUM)vs › | $43.72B | $39.59B |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.33B | $80.33B |
| Boston Scientific Corporation (BSX)vs › | $69.74B | $151.53B |
| Agilent Technologies, Inc. (A)vs › | $36.04B | $42.98B |
| Zoetis Inc. (ZTS)vs › | $33.26B | $62.97B |
| Medline Inc. (MDLN)vs › | $31.36B | $44.73B |
Enterprise Value Calculation
Market Cap
$53.10B
Total Debt
$8.53B
Cash
$3.87B
Enterprise Value
$57.76B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Cardinal Health, Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Cardinal Health, Inc. (CAH)?
- The enterprise value (EV) for CAH stock is $57.76B.
Related Metrics
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar